|
[1]
|
郑梦莹. 我国预估有8200万成人患慢性肾脏病知晓率仅10% [J]. 中华医学信息导报, 2023, 38(5): 14-14.
|
|
[2]
|
Sharaf El Din, U.A., Salem, M.M. and Abdulazim, D.O. (2016) Vascular Calcification: When Should We Interfere in Chronic Kidney Disease Patients and How? World Journal of Nephrology, 5, 398-417. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
苏凯杰. 慢性肾病患者的胰岛素抵抗与心血管并发症[J]. 医学研究生学报, 2016, 29(6): 653-657.
|
|
[4]
|
Cozzolino, M., Mazzaferro, S., Pugliese, F. and Brancaccio, D. (2008) Vascular Calcification and Uremia: What Do We Know? American Journal of Nephrology, 28, 339-346. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Disthabanchong, S. (2012) Vascular Calcification in Chronic Kidney Dis-ease: Pathogenesis and Clinical Implication. World Journal of Nephrology, 1, 43-53. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Fang, K., Chen, Z., Liu, M., Peng, J. and Wu, P. (2015) Apoptosis and Calcification of Vascular Endothelial Cell under Hyperhomocysteinemia. Medical Oncology, 32, Article No. 403. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Liu, J., Ma, K.L., Gao, M., Wang, C.X., Ni, J., Zhang, Y., Zhang, X.L., Liu, H., Wang, Y.L. and Liu, B.C. (2012) Inflammation Disrupts the LDL Receptor Pathway and Accelerates the Progression of Vascular Calcification in ESRD Patients. PLOS ONE, 7, e47217. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Yang, X., Soohoo, M., Streja, E., Rivara, M.B., Obi, Y., Adams, S.V., Kalantar-Zadeh, K. and Mehrotra, R. (2016) Serum Magnesium Levels and Hospitalization and Mortality in Inci-dent Peritoneal Dialysis Patients: A Cohort Study. American Journal of Kidney Diseases, 68, 619-627. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ishimura, E., Okuno, S., Yamakawa, T., Inaba, M. and Nishizawa, Y. (2007) Serum Magnesium Concentration Is a Significant Predictor of Mortality in Maintenance Hemodialysis Patients. Magnesium Research, 20, 237-244.
|
|
[10]
|
Sakaguchi, Y., Fujii, N., Shoji, T., Hayashi, T., Rakugi, H., Iseki, K., Tsu-bakihara, Y., Isaka, Y. and Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy (2014) Mag-nesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemo-dialysis: A Cohort Study. PLOS ONE, 9, e116273. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kircelli, F., Peter, M.E., Ok, E.S., Celenk, F.G., Yilmaz, M., Steppan, S., Asci, G., Ok, E. and Passlick-Deetjen, J. (2012) Magne-sium Reduces Calcification in Bovine Vascular Smooth Muscle Cells in a Dose-Dependent Manner. Nephrology Dialysis Transplantation, 27, 514-521. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Montes de Oca, A., Guerrero, F., Mar-tinez-Moreno, J.M., Madueño, J.A., Herencia, C., Peralta, A., Almaden, Y., Lopez, I., Aguilera-Tejero, E., Gundlach, K., Büchel, J., Peter, M.E., Passlick-Deetjen, J., Rodriguez, M. and Muñoz-Castañeda, J.R. (2014) Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells. PLOS ONE, 9, e89525. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
陈西霞, 张凌, 王勇, 等. 低镁血症加重慢性肾脏病患者心血管钙化的病理机制[J]. 临床肾脏病杂志, 2021, 21(7): 594-598.
|
|
[14]
|
Hsu, S.P., Pai, M.F., Peng, Y.S., Chiang, C.K., Ho, T.I. and Hung, K.Y. (2004) Serum Uric Acid Levels Show a “J-Shaped” Association with All-Cause Mortality in Haemodialysis Patients. Nephrology Dialysis Transplantation, 19, 457-462. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
宋哲, 赵阳, 王宪, 徐明江. 慢性肾功能衰竭继发高尿酸血症促进血管钙化[J]. 生理学报, 2016, 68(6): 709-715.
|
|
[16]
|
田芳, 李浩, 刘雪梅, 等. 维持性血液透析患者血尿酸与冠脉钙化的相关性研究[J]. 中国中西医结合肾病杂志, 2018, 19(4): 324-326.
|
|
[17]
|
Latif, W., Karaboyas, A., Tong, L., Winchester, J.F., Arrington, C.J., Pisoni, R.L., Marshall, M.R., Kleophas, W., Levin, N.W., Sen, A., Robinson, B.M. and Saran, R. (2011) Uric acid Levels and All-Cause and Cardiovascular Mortality in the Hemodialysis Population. Clin-ical Journal of the American Society of Nephrology, 6, 2470-2477. [Google Scholar] [CrossRef]
|
|
[18]
|
Russo, D., Morrone, L.F., Imbriaco, M., Pota, A., Russo, L., Scog-namiglio, B. and Sorrentino, R. (2013) Coronary Artery Calcification and Outcomes in Diabetic Patients with and without Chronic Kidney Disease. Blood Purification, 36, 17-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Fadini, G.P., Pau-letto, P., Avogaro, A. and Rattazzi, M. (2007) The Good and the Bad in the Link between Insulin Resistance and Vascu-lar Calcification. Atherosclerosis, 193, 241-244. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Cano-Megías, M., Bouarich, H., Guisado-Vasco, P., Pérez Fernández, M., de Arriba-de la Fuente, G., Álvarez-Sanz, C. and Rodríguez-Puyol, D. (2019) Coronary Artery Calcification in Patients with Diabetes Mellitus and Advanced Chronic Kidney Disease. Endocrinología, Diabetes y Nu-trición (Engl Ed), 66, 297-304. [Google Scholar] [CrossRef]
|
|
[21]
|
Chen, N.X., Duan, D., O’Neill, K.D. and Moe, S.M. (2006) High Glucose Increases the Expression of Cbfa1 and BMP-2 and Enhances the Calcification of Vascular Smooth Muscle Cells. Nephrology Dialysis Transplantation, 21, 3435-3442. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
孙春晓, 郭兆安. 慢性肾脏病血脂代谢紊乱的影响因素及其机制的研究进展[J]. 中国中西医结合肾病杂志, 2014(6): 546-548.
|
|
[23]
|
Wang, Y.N., Sun, Y., Wang, Y. and Jia, Y.L. (2015) Serum S100A12 and Progression of Coronary Ar-tery Calcification over 4 Years in Hemodialysis Patients. American Journal of Nephrology, 42, 4-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Tamashiro, M., Iseki, K., Sunagawa, O., Inoue, T., Higa, S., Afuso, H. and Fukiyama, K. (2001) Significant Association between the Progression of Coronary Artery Calcification and Dyslipidemia in Patients on Chronic Hemodialysis. American Journal of Kidney Diseases, 38, 64-69. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Kameda, T., Ohkawa, R., Yano, K., Usami, Y., Miyazaki, A., Matsuda, K., Kawasaki, K., Sugano, M., Kubota, T. and Tozuka, M. (2015) Effects of Myeloperoxidase-Induced Oxida-tion on Antiatherogenic Functions of High-Density Lipoprotein. Journal of Lipids, 2015, Article ID: 592594. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Yamamoto, S., Yancey, P.G., Ikizler, T.A., Jerome, W.G., Kaseda, R., Cox, B., Bian, A., Shintani, A., Fogo, A.B., Linton, M.F., Fazio, S. and Kon, V. (2012) Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis. Journal of the American College of Cardiology, 60, 2372-2379. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Parhami, F., Morrow, A.D., Balucan, J., Leitinger, N., Watson, A.D., Tintut, Y., Berliner, J.A. and Demer, L.L. (1997) Lipid Oxidation Products Have Opposite Effects on Calcifying Vascular Cell and Bone Cell Differentiation. A Possible Explanation for the Paradox of Arterial Calcification in Osteo-porotic Patients. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 680-687. [Google Scholar] [CrossRef]
|
|
[28]
|
Mathew, S., Tustison, K.S., Sugatani, T., Chaudhary, L.R., Rifas, L. and Hruska, K.A. (2008) The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKD. Journal of the Amer-ican Society of Nephrology, 19, 1092-1105. [Google Scholar] [CrossRef]
|
|
[29]
|
Kurnatowska, I., Grzelak, P., Kaczmarska, M., Stefańczyk, L. and Nowicki, M. (2011) Serum Osteoprotegerin Is a Predictor of Progression of Atherosclerosis and Coronary Calcification in Hemodialysis Patients. Nephron Clinical Practice, 117, c297-c304. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Block, G.A., Klassen, P.S., Lazarus, J.M., Ofsthun, N., Lowrie, E.G. and Chertow, G.M. (2004) Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis. Journal of the American Society of Nephrology, 15, 2208-2218. [Google Scholar] [CrossRef]
|
|
[31]
|
Bosworth, C., Sachs, M.C., Duprez, D., Hoofnagle, A.N., Ix, J.H., Jacobs Jr., D.R., Peralta, C.A., Siscovick, D.S., Kestenbaum, B. and de Boer, I.H. (2013) Parathyroid Hormone and Arterial Dysfunction in the Multi-Ethnic Study of Atherosclerosis. Clinical Endocrinology (Oxf), 79, 429-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Coen, G., Manni, M., Mantella, D., Pierantozzi, A., Balducci, A., Condò, S., DiGiulio, S., Yancovic, L., Lippi, B., Manca, S., Morosetti, M., Pellegrino, L., Simonetti, G., Gallucci, M.T. and Splendiani, G. (2007) Are iPTH Serum Levels Predictive of Coronary Calcifications in Haemodialysis Patients? Nephrology Dialysis Transplantation, 22, 3262-3267. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Yamashita, T., Yoshioka, M. and Itoh, N. (2000) Identification of a Novel Fibroblast Growth Factor, FGF-23, Preferentially Expressed in the Ventrolateral Thalamic Nucleus of the Brain. Biochemical and Biophysical Research Communications, 277, 494-498. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Singh, S., Grabner, A., Yanucil, C., Schramm, K., Czaya, B., Krick, S., Czaja, M.J., Bartz, R., Abraham, R., Di Marco, G.S., Brand, M., Wolf, M. and Faul, C. (2016) Fibroblast Growth Factor 23 Directly Targets Hepatocytes to Promote Inflammation in Chronic Kidney Disease. Kidney Interna-tional, 90, 985-996. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Mirza, M.A., Alsiö, J., Hammarstedt, A., Erben, R.G., Michaëlsson, K., Tivesten, A., Marsell, R., Orwoll, E., Karlsson, M.K., Ljunggren, O., Mellström, D., Lind, L., Ohlsson, C. and Lars-son, T.E. (2011) Circulating Fibroblast Growth Factor-23 Is Associated with Fat Mass and Dyslipidemia in Two Inde-pendent Cohorts of Elderly Individuals. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 219-227. [Google Scholar] [CrossRef]
|
|
[36]
|
Zheng, S., Zheng, Y., Jin, L., Zhou, Z. and Li, Z. (2018) Re-lationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis. Iranian Journal of Public Health, 47, 510-518.
|
|
[37]
|
Hu, M.C., Shi, M., Zhang, J., Qui-ñones, H., Griffith, C., Kuro-o, M. and Moe, O.W. (2011) Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease. Journal of the American Society of Nephrology, 22, 124-136. [Google Scholar] [CrossRef]
|
|
[38]
|
Hum, J.M., O’Bryan, L.M., Tatiparthi, A.K., Cass, T.A., Clinken-beard, E.L., Cramer, M.S., Bhaskaran, M., Johnson, R.L., Wilson, J.M., Smith, R.C. and White, K.E. (2017) Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho. Journal of the Amer-ican Society of Nephrology, 28, 1162-1174. [Google Scholar] [CrossRef]
|
|
[39]
|
Ikushima, M., Rakugi, H., Ishikawa, K., Maekawa, Y., Yamamoto, K., Ohta, J., Chihara, Y., Kida, I. and Ogihara, T. (2006) Anti-Apoptotic and Anti-Senescence Effects of Klotho on Vas-cular Endothelial Cells. Biochemical and Biophysical Research Communications, 339, 827-832. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Utsugi, T., Ohno, T., Ohyama, Y., Uchiyama, T., Saito, Y., Matsumura, Y., Aizawa, H., Itoh, H., Kurabayashi, M., Kawazu, S., Tomono, S., Oka, Y., Suga, T., Kuro-o, M., Na-beshima, Y. and Nagai, R. (2000) Decreased Insulin Production and Increased Insulin Sensitivity in the Klotho Mutant Mouse, a Novel Animal Model for Human Aging. Metabolism, 49, 1118-1123. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Mori, Y., Kosaki, A., Kishimoto, N., Kimura, T., Iida, K., Fukui, M., Nakajima, F., Nagahara, M., Urakami, M., Iwasaka, T. and Matsubara, H. (2009) Increased Plasma S100A12 (EN-RAGE) Levels in Hemodialysis Patients with Atherosclerosis. American Journal of Nephrology, 29, 18-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Gawdzik, J., Mathew, L., Kim, G., Puri, T.S. and Hofmann Bowman, M.A. (2011) Vascular Remodeling and Arterial Calcification Are Directly Mediated by S100A12 (EN-RAGE) in Chronic Kidney Disease. American Journal of Nephrology, 33, 250-259. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Nakahara, T., Dweck, M.R., Narula, N., et al. (2017) Coronary Artery Calcification: From Mechanism to Molecular Imaging. JACC: Cardiovascular Imaging, 10, 582-593. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Wang, Y., Osborne, M.T., Tung, B., et al. (2018) Imaging Cardi-ovascular Calcification. Journal of the American Heart Association, 7, e008564. [Google Scholar] [CrossRef]
|
|
[45]
|
Smith, E.R., Hewitson, T.D. and Holt, S.G. (2019) Diagnostic Tests for Vascular Calcification. Advances in Chronic Kidney Disease, 26, 445-463. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Lopez, I., Mendoza, F.J., Aguilera-Tejero, E., et al. (2008) The Ef-fect of Calcitriol, Paricalcitol, and a Calcimimetic on Extraosseous Calcifications in Uremic Rats. Kidney International, 73, 300-307. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Cozzolino, M., Staniforth, M.E., Liapis, H., et al. (2003) Sevelamer Hydrochloride Attenuates Kidney and Cardiovascular Calcifications in Long-Term Experimental Uremia. Kid-ney International, 64, 1653-1661. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Lau, W.L., Leaf, E.M., Hu, M.C., et al. (2012) Vitamin D Receptor Agonists Increase Klotho and Osteopontin While Decreasing Aortic Calcification in Mice with Chronic Kidney Disease Fed a High Phosphate Diet. Kidney International, 82, 1261-1270. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Oca, A., Guerrero, F., Martinez-Moreno, J.M., et al. (2014) Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells. PLOS ONE, 9, e89525. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Sakaguchi, Y., Hamano, T., Obi, Y., et al. (2019) A Random-ized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD. JASN, 30, 1073-1085. [Google Scholar] [CrossRef]
|